Scynexis (SCYX) Free Cash Flow (QoQ) (2013 - 2026)
Scynexis (SCYX) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn |
| 3 | Zoetis | 31.48 Bn | 29.80 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -83.74% |
| Mar 31, 2026 | -144.02% |
| Dec 31, 2025 | 310.92% |
| Sep 30, 2025 | -16.40% |
| Jun 30, 2025 | -0.40% |
| Mar 31, 2025 | 24.65% |
| Dec 31, 2024 | -1,395.03% |
| Sep 30, 2024 | 107.04% |
| Jun 30, 2024 | -171.03% |
| Mar 31, 2024 | 48.20% |
| Dec 31, 2023 | -162.28% |
| Sep 30, 2023 | -83.31% |
| Jun 30, 2023 | 493.16% |
| Mar 31, 2023 | 17.03% |
| Dec 31, 2022 | -1.32% |
| Sep 30, 2022 | -21.13% |
| Jun 30, 2022 | -16.22% |
| Mar 31, 2022 | 36.16% |
| Dec 31, 2021 | -48.87% |
| Sep 30, 2021 | -42.09% |